Log In
Print
BCIQ
Print
Print this Print this
 

DPX-Survivac

  Manage Alerts
Collapse Summary General Information
Company Immunovaccine Inc.
DescriptionVaccine comprising survivin (BIRC5)-based peptide antigens formulated using DepoVax adjuvanting platform
Molecular Target Survivin (BIRC5)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today